AKBA icon

Akebia Therapeutics
AKBA

Overview Fund Activity

118 hedge funds and large institutions have $392M invested in Akebia Therapeutics in 2017 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 12 closing their positions.

Holders
118
Holders Change
+29
Holders Change %
+32.58%
% of All Funds
2.95%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
41
Increased
38
Reduced
28
Closed
12
Calls
$1.99M
Puts
$863K
Net Calls
+$1.13M
Net Calls Change
+$519K

Top Buyers

1
PA
1
Perceptive Advisors
New York
$15.8M
2
RCM
2
RA Capital Management
Massachusetts
$12M
3
FCM
3
Farallon Capital Management
California
$10.5M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$14.7M
5
NI
5
Numeric Investors
Massachusetts
$8.94M

Top Sellers

1
MWNA
1
Marshall Wace North America
New York
$5.46M
2
ACA
2
Avoro Capital Advisors
New York
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$10.1M
4
NCM
4
Nantahala Capital Management
Connecticut
$30.9M
5
CFIC
5
City Financial Investment Company
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
JPMorgan Chase & Co
126
JPMorgan Chase & Co
New York
– – -12,650 Closed
LPL Financial
127
LPL Financial
California
– – -10,062 Closed
Parallax Volatility Advisers
128
Parallax Volatility Advisers
California
– – -879 Closed
Carson Wealth (CWM LLC)
129
Carson Wealth (CWM LLC)
Nebraska
$0 31 – –
IA
130
IFP Advisors
Florida
$0 28 – –
2 3 4 5
6